Identificación indirecta de reacción de hipersensibilidad a etopósido mediada por polisorbato 80

Pantín, Carmen; Letellez, Javier; Calzas, Julia; Mohedano, Ester.
Farm. hosp ; 42(1): 27-28, ene.-feb. 2018. tab
Artículo en Español | IBECS (España) | ID: ibc-169912

Documentos relacionados

  1. Institutional Determinants of Mining Projects in Canada and Sweden: Insights from the Prosperity and Kallak Cases.
  2. Old is gold: frontline etoposide for pHLH.
  3. Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma.
  4. Etoposide-Entrapped Progesterone-Cationic Lipid Nanoaggregates as Selective Therapeutics against Etoposide-Resistant Colorectal Cancer Cells.
  5. A Study on the Optimal Magnetic Beam Forming of Coil Arrays for Long Distance Wireless Power Transmission.
  6. Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
  7. Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma.
  8. KCTD5 regulates Ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.
  9. Lysosome Fe<sup>2+</sup> release is responsible for etoposide- and cisplatin-induced stemness of small cell lung cancer cells.
  10. Professionals' adaptive expertise and adaptive performance in educational and workplace settings: an overview of reviews.